Kailera Therapeutics, Inc. Balance Sheet
Kailera Therapeutics, Inc.'s total assets for Q2 2026 were $1.21B, an increase of 93.90% from the previous quarter. KLRA total liabilities were $92.95M for the fiscal quarter, a -91.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
